COVID Vaccine Update
November 11, 2020
157,584
5,524
2,058
4.81%
Search the Record
IndexedEvery word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Dr John Campbell Episodes Around November 11, 2020
See what was published immediately before and after this episode.
20:07Now PlayingCOVID Vaccine Update
YouTube Description
as posted by the channelPfizer / BioNTech
m RNA
N = 43,538 participants
94 people infected so far
90% effective
Antibodies and T cells
Mostly mild to moderate side effects
RNA falls apart
Minus 80 degrees Celsius (minus 112 degrees Fahrenheit)
Dry Ice, -78 degrees Celsius
AstraZeneca / University of Oxford
Chimpanzee adenovirus
US, 1.2 billion for 300 million doses
EU, 400 million doses
Indian studies and production
India’s Serum Institute
2 billion doses next year
Results from trial by end of December
Moderna / National Institutes of Health
mRNA, to produce viral proteins in the body
Providing nearly $1 billion in support
October, finished recruiting 30,000
Including 7,000 people 65 years +
Emergency use authorization by the end of 2020
US, 100 million doses
Canada, Japan, Qatar
Johnson & Johnson
Adenovirus based
Ebola technology
US funding, 456 million
US, One billion for 100 million doses
EU, 200 million doses
Phase 3 launched in September, 60,000
Single dose vaccine
Results in December
Brazil
Halted phase 3 trial of a Chinese vaccine
Serious adverse incident reaction in a participant, 29th October
CoronaVac (Sinovac)
One of 11 vaccines currently at stage 3 trials
Patient confidentiality
Officials in China allowed emergency use
Tens of thousands of doses already given
Russia
Sputnik V
Two human adenoviruses (common cold)
92 per cent effective
Interim results, 16,000 trial participants
Two-dose vaccine, 3 weeks apart
Domestic Rollout
Phase three study, Gamaleya Institute
29 clinics across Moscow
40,000 volunteers in total
A quarter receiving a placebo shot.
Turkey to start production
Guests & Subjects Covered
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.